Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Approval for Diabetes and Weight Management Over the past decade, three GLP-1/GIP receptor agonists liraglutide, semaglutide, and tirzepatide initially approved by the FDA for adults with type 2 diabetes, have also gained FDA approval for chronic weight management in people without diabetes, provided they meet specific criteria: a BMI of 30, or 27 with at least one weight-related condition such as hypertension, dyslipidemia, or type 2 diabetes
2 vials 12 weeks approx
Read about the other prescription drugs California is targeting for discounts: ow.ly/gAje50XcFMq Damian Dovarganes/AP To view or add a comment, sign in Today, the FDA announced approval of GSKs Blenrep (belantamab mafodotin) to treat patients with relapsed/refractory multiple myeloma that has progressed after at least two prior lines of treatment
Reach out to us if you are interested in taking this opportunity to the next stage
Nothing on this page guarantees prescribing, approval, or specific outcomes
